StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
632
This month
11
This week
1
This year
60
Yesterday
1
Publishing Date
2024 - 04 - 16
3
2024 - 02 - 14
4
2024 - 01 - 30
3
2023 - 12 - 06
3
2023 - 11 - 28
3
2023 - 10 - 04
3
2023 - 09 - 11
3
2023 - 09 - 06
3
2023 - 08 - 30
3
2023 - 08 - 25
3
2023 - 05 - 19
3
2023 - 05 - 17
3
2023 - 05 - 03
3
2023 - 04 - 14
5
2023 - 04 - 13
5
2023 - 04 - 12
3
2023 - 03 - 28
4
2023 - 03 - 10
4
2023 - 02 - 27
4
2023 - 02 - 17
3
2023 - 02 - 08
3
2023 - 01 - 11
3
2023 - 01 - 04
4
2023 - 01 - 03
3
2022 - 12 - 16
3
2022 - 11 - 21
3
2022 - 10 - 06
4
2022 - 09 - 29
3
2022 - 09 - 28
3
2022 - 09 - 27
3
2022 - 09 - 26
3
2022 - 09 - 19
5
2022 - 09 - 15
4
2022 - 09 - 12
3
2022 - 09 - 08
5
2022 - 09 - 07
3
2022 - 09 - 05
3
2022 - 08 - 29
3
2022 - 08 - 25
3
2022 - 08 - 03
4
2022 - 07 - 27
3
2022 - 07 - 14
3
2022 - 06 - 29
3
2022 - 06 - 24
4
2022 - 06 - 09
3
2022 - 05 - 31
3
2022 - 05 - 17
3
2022 - 04 - 26
3
2022 - 04 - 04
4
2022 - 03 - 07
3
2022 - 02 - 28
3
2022 - 02 - 09
3
2022 - 01 - 19
3
2021 - 12 - 08
3
2021 - 10 - 27
3
2021 - 10 - 22
3
2021 - 10 - 21
3
2021 - 10 - 08
2
2021 - 10 - 01
2
2021 - 09 - 30
2
Sector
Communications
6
Consumer durables
1
Consumer non-durables
13
Electronic technology
2
Finance
6
Finance and insurance
1
Health services
1
Health technology
632
Manufacturing
65
Mining, quarrying, and oil and gas extraction
1
N/a
122
Process industries
14
Producer manufacturing
9
Professional, scientific, and technical services
3
Retail trade
2
Technology services
1
Tags
Active
10
Agreement
8
Ajovy
8
Alzheimer's
9
America
38
Application
11
Approval
13
Asia
13
Austedo
9
Avt02
11
Avt04
11
Biosimilar
41
Business
12
Cancer
21
Children
18
Clinical-trials-phase-iii
8
Collaboration
9
Conference
20
Dermatitis
8
Disease
36
Drug
44
Dupixent
34
Earnings
14
Europe
15
Events
10
Expected
12
Fda
22
Financial
21
Global
111
Growing
17
Growth
133
Health
11
Libtayo
8
License
11
Liver
8
Market
314
Migraine
9
N/a
515
Pharm-country
18
Pharma
12
Pharmaceuticals
9
Phase 3
15
Positive
14
Reach
16
Report
95
Research
59
Respiratory
10
Results
47
Review
8
Set
13
Stelara
12
Study
20
System
11
Teva
53
Therapeutics
64
Therapy
14
Treatment
76
Trial
12
Update
20
Year
8
Entities
3m company
938
Abb ltd
1433
Abbott laboratories
1796
Abbvie inc.
1029
Accenture plc
602
Alphabet inc.
1302
Amgen inc.
744
Apple inc.
1198
Arcelormittal
592
Arrival
4308
Astrazeneca plc
667
Bank of montreal
545
Becton, dickinson and company
796
Bnp paribas
1767
Boston scientific corporation
576
Bristol-myers squibb company
662
Broadcom inc.
597
Cisco systems, inc.
900
Cummins inc.
542
Danaher corporation
786
Dell technologies inc.
579
Dow inc.
556
Eli lilly and company
1710
Ericsson
1614
Extreme networks, inc.
581
First bank
600
Ford motor company
643
Gartner, inc.
595
General electric company
918
Glaxosmithkline plc
888
Honeywell international inc.
1791
Hubspot, inc.
1400
Intel corporation
955
International business machines corporation
655
Johnson & johnson
4595
Kering
1132
Koninklijke philips n.v.
963
Lithium corp
972
Live nation entertainment, inc.
717
Lockheed martin corporation
576
Medtronic plc
1286
Microsoft corporation
1203
Morgan stanley
4291
Nokia corp
980
Nokia corporation
904
Northrop grumman corporation
589
Novartis ag
1244
Novo nordisk a/s
634
Oracle corporation
1160
Orange
7217
Panasonic corp
651
Pfizer, inc.
693
Sanofi
4551
Sap se
1480
Snowflake inc.
796
Stryker corporation
536
Teva pharmaceutical industries ltd
632
Thermo fisher scientific inc
1627
Verizon communications inc.
1221
X financial
678
Symbols
ABBV
130
ABT
43
ALB
8
ALC
4
ALKS
5
ALNY
4
ALPMF
27
ALPMY
27
ALVO
83
AMGN
83
ATR
5
ATRS
4
AVDL
4
AZN
85
AZNCF
85
BAX
25
BDX
4
BHC
33
BIIB
28
BMY
37
CMPI
4
CMXHF
6
CSLLY
6
DNLI
5
ENDP
28
ENDPQ
19
FNCTF
6
GILD
10
GLAXF
148
GSK
148
JAZZ
8
JNJ
80
KMDA
85
LLY
61
MDT
9
MMM
9
MNK
15
MNKKQ
13
MNKPF
10
MS
5
NTLA
6
NVO
15
NVS
206
NVSEF
206
PFE
29
PHG
12
PRGO
6
RBGLY
11
RBGPF
11
REGN
72
SNY
224
SNYNF
224
TAK
20
TARO
5
TEVA
64
TEVJF
632
TMO
8
UCBJF
7
UCBJY
7
VTRS
103
Exchanges
Nasdaq
632
Nyse
435
Crawled Date
2024 - 04 - 16
3
2024 - 02 - 14
4
2024 - 01 - 30
3
2024 - 01 - 19
3
2023 - 12 - 06
3
2023 - 11 - 28
3
2023 - 10 - 04
3
2023 - 09 - 11
3
2023 - 09 - 06
3
2023 - 08 - 30
3
2023 - 08 - 25
3
2023 - 05 - 17
3
2023 - 05 - 03
3
2023 - 04 - 14
5
2023 - 04 - 13
6
2023 - 03 - 28
4
2023 - 03 - 10
3
2023 - 02 - 27
4
2023 - 02 - 17
3
2023 - 01 - 04
4
2023 - 01 - 03
3
2022 - 12 - 16
3
2022 - 11 - 21
3
2022 - 10 - 06
4
2022 - 09 - 28
3
2022 - 09 - 27
3
2022 - 09 - 26
3
2022 - 09 - 19
5
2022 - 09 - 15
4
2022 - 09 - 12
3
2022 - 09 - 08
5
2022 - 09 - 07
3
2022 - 09 - 05
4
2022 - 08 - 29
3
2022 - 08 - 25
3
2022 - 08 - 03
4
2022 - 07 - 27
3
2022 - 07 - 14
3
2022 - 06 - 29
3
2022 - 06 - 24
4
2022 - 06 - 09
3
2022 - 05 - 31
3
2022 - 05 - 17
3
2022 - 04 - 26
3
2022 - 04 - 04
4
2022 - 03 - 07
3
2022 - 02 - 28
3
2022 - 02 - 09
3
2022 - 01 - 19
3
2021 - 12 - 08
3
2021 - 11 - 25
2
2021 - 11 - 12
2
2021 - 11 - 04
2
2021 - 10 - 27
3
2021 - 10 - 22
2
2021 - 10 - 21
3
2021 - 10 - 14
2
2021 - 10 - 08
2
2021 - 10 - 01
2
2021 - 09 - 30
2
Crawled Time
00:00
32
00:20
6
01:00
17
02:00
12
03:00
14
04:00
9
04:20
5
05:00
10
06:00
16
07:00
16
08:00
25
08:20
1
09:00
43
10:00
24
11:00
23
12:00
44
12:15
1
12:20
9
12:30
3
13:00
36
13:20
8
13:30
7
14:00
19
14:20
2
14:30
5
15:00
21
15:20
1
15:30
9
16:00
26
16:20
4
17:00
23
18:00
24
19:00
23
20:00
21
20:20
4
21:00
24
22:00
30
23:00
35
Source
ir.biolinerx.com
1
ir.vtvtherapeutics.com
1
www.biospace.com
117
www.globenewswire.com
95
www.prnewswire.com
418
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Teva pharmaceutical industries ltd
save search
The Europe Probiotics Market to Worth $18.76 Billion by 2028 - Arizton
Published:
2023-07-05
(Crawled : 18:00)
- prnewswire.com
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-14.51%
|
O:
-1.61%
H:
0.06%
C:
-0.51%
europe
market
Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published:
2023-06-30
(Crawled : 23:00)
- prnewswire.com
ALKS
|
$24.26
0.79%
0.78%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
Email alert
Add to watchlist
NBIX
|
News
M
|
$140.11
4.83%
4.6%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
UCBJY
|
$64.93
-4.38%
6.2K
|
Manufacturing
|
Email alert
Add to watchlist
UCBJF
|
$128.725
-39.66%
750
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
Email alert
Add to watchlist
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
Email alert
Add to watchlist
report
business
life
global
therapeutics
Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Report 2023: Increasing Prevalence of Lung Disease Drives Growth
Published:
2023-06-28
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
18.09%
|
O:
1.75%
H:
0.06%
C:
0.06%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
-1.19%
|
O:
1.06%
H:
0.72%
C:
0.72%
ALPMY
|
News
|
$9.53
-1.11%
690K
|
Manufacturing
|
-37.18%
|
O:
-1.98%
H:
0.0%
C:
-0.47%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-3.73%
|
O:
0.17%
H:
0.85%
C:
0.76%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
14.24%
|
O:
-1.21%
H:
1.17%
C:
0.91%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-0.5%
|
O:
-0.54%
H:
0.78%
C:
0.59%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-14.26%
|
O:
-1.86%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
-1.17%
|
O:
-0.83%
H:
0.89%
C:
0.68%
lung
disease
report
treatment
global
growth
market
Alvotech Provides Regulatory Update on Second Biologics License Application for AVT02
Published:
2023-06-28
(Crawled : 23:00)
- globenewswire.com
ALVO
|
$13.39
0.45%
0.45%
200K
|
n/a
|
81.36%
|
O:
-6.26%
H:
4.93%
C:
0.15%
KMDA
|
$5.1
-0.99%
5.3K
|
Health Technology
|
-4.24%
|
O:
-0.74%
H:
1.12%
C:
0.19%
avt02
license
update
application
Nasal Drug Delivery Technology Global Market Report 2023: Major Players Include AptarGroup, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer and 3M
Published:
2023-06-23
(Crawled : 22:00)
- prnewswire.com
BHC
|
$8.53
0.95%
0.0%
4M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
Email alert
Add to watchlist
ATR
|
$140.15
-0.12%
0.0%
420K
|
Process Industries
|
Email alert
Add to watchlist
BDX
|
$234.36
0.21%
0.0%
800K
|
Health Technology
|
Email alert
Add to watchlist
MDT
|
$81.29
0.89%
0.0%
5.2M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
drug
report
global
technology
market
Global Remifentanil Hydrochloride Market to Surpass USD 346.7 Mn By 2031| Growth Market Reports
Published:
2023-06-23
(Crawled : 14:00)
- prnewswire.com
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-5.74%
|
O:
0.17%
H:
0.64%
C:
-0.02%
global
growth
market
Generic Central Nervous System Drugs Global Market Report 2023: Major Players Include Otsuka Pharmaceutical, Astra Zeneca, Shire, Novartis and Teva Pharmaceutical Industries
Published:
2023-06-19
(Crawled : 00:00)
- prnewswire.com
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
12.01%
|
O:
0.02%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-6.93%
|
O:
-0.39%
H:
0.06%
C:
-0.61%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
15.48%
|
O:
-1.0%
H:
0.32%
C:
-0.52%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
63.35%
|
O:
-0.41%
H:
2.02%
C:
1.37%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
21.1%
|
O:
-1.11%
H:
1.35%
C:
0.53%
ALKS
|
$24.26
0.79%
0.78%
1.2M
|
Health Technology
|
-25.23%
|
O:
0.47%
H:
0.46%
C:
0.28%
report
global
system
novartis
teva
market
Fibromyalgia Treatment Market to Reach $4.6 Billion, Globally, by 2032 at 4.0% CAGR: Allied Market Research
Published:
2023-06-16
(Crawled : 14:00)
- prnewswire.com
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
13.0%
|
O:
0.75%
H:
0.14%
C:
0.14%
VTRS
|
News
A
|
$11.36
0.98%
0.97%
4.7M
|
Health Technology
|
13.18%
|
O:
0.6%
H:
3.2%
C:
2.9%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-6.53%
|
O:
1.03%
H:
0.29%
C:
-0.59%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
61.11%
|
O:
0.41%
H:
0.26%
C:
-1.77%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
23.55%
|
O:
0.6%
H:
1.62%
C:
1.42%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
1.95%
|
O:
0.4%
H:
1.07%
C:
0.72%
fibromyalgia
reach
treatment
research
market
Global Doxorubicin Strategic Analysis Report 2023: A $1.7 Billion Market by 2030 from $1.1 Billion in 2022 - US Dominates the Market, Asia-Pacific to Witness Fastest Growth
Published:
2023-06-14
(Crawled : 19:00)
- prnewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-33.28%
|
O:
0.13%
H:
1.07%
C:
0.86%
report
global
doxorubicin
growth
market
Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®
Published:
2023-06-12
(Crawled : 07:00)
- globenewswire.com
ALVO
|
$13.39
0.45%
0.45%
200K
|
n/a
|
62.56%
|
O:
-0.98%
H:
1.96%
C:
-8.62%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-6.81%
|
O:
-0.01%
H:
0.16%
C:
-0.06%
KMDA
|
$5.1
-0.99%
5.3K
|
Health Technology
|
-2.63%
|
O:
-1.5%
H:
1.71%
C:
0.57%
avt04
stelara
biosimilar
license
teva
Global Opioid Induced Constipation Markets to 2030: Revenues, Trends, Competitive Assessment & Intelligence
Published:
2023-06-09
(Crawled : 22:00)
- prnewswire.com
BHC
|
$8.53
0.95%
0.0%
4M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
Email alert
Add to watchlist
IRWD
|
$8.305
3.04%
2.95%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
VTRS
|
News
A
|
$11.36
0.98%
0.97%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
opioid
global
Teva Presents Real-World Data for AUSTEDO® (deutetrabenazine) Tablets with 4-Week Patient Titration Kit at Psych Congress Elevate 2023
Published:
2023-06-02
(Crawled : 23:00)
- biospace.com/
TEVA
|
$13.01
1.01%
0.0%
8.9M
|
Health Technology
|
78.89%
|
O:
0.69%
H:
0.14%
C:
-0.28%
austedo
teva
Peptide Therapeutics Global Market Report 2023: Increase in the Prevalence of Chronic Diseases Drives Growth
Published:
2023-06-01
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-8.59%
|
O:
-0.56%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
-6.07%
|
O:
-0.74%
H:
1.4%
C:
0.35%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
17.43%
|
O:
0.99%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-15.92%
|
O:
1.32%
H:
0.31%
C:
0.12%
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-30.93%
|
O:
0.6%
H:
1.07%
C:
0.29%
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
-20.71%
|
O:
-1.84%
H:
1.62%
C:
1.33%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-2.41%
|
O:
1.03%
H:
0.84%
C:
0.82%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-24.03%
|
O:
0.37%
H:
1.34%
C:
1.14%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-7.89%
|
O:
1.05%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
-3.72%
|
O:
0.11%
H:
0.69%
C:
-0.45%
report
global
therapeutics
growth
market
Alvotech to Participate in 2023 Jefferies Healthcare Conference
Published:
2023-05-31
(Crawled : 11:00)
- biospace.com/
ALVO
|
$13.39
0.45%
0.45%
200K
|
n/a
|
63.16%
|
O:
-3.06%
H:
8.59%
C:
6.44%
KMDA
|
$5.1
-0.99%
5.3K
|
Health Technology
|
4.22%
|
O:
-0.92%
H:
0.0%
C:
-2.11%
conference
Alvotech to Participate in Jefferies Healthcare Conference
Published:
2023-05-31
(Crawled : 09:00)
- globenewswire.com
ALVO
|
$13.39
0.45%
0.45%
200K
|
n/a
|
63.16%
|
O:
-3.06%
H:
8.59%
C:
6.44%
KMDA
|
$5.1
-0.99%
5.3K
|
Health Technology
|
4.22%
|
O:
-0.92%
H:
0.0%
C:
-2.11%
conference
Global Generic Injectables Market Report 2023: Aging Population and Rising Prevalence of Chronic Diseases Drives Growth
Published:
2023-05-26
(Crawled : 02:00)
- prnewswire.com
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
64.93%
|
O:
-3.33%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-11.8%
|
O:
0.5%
H:
1.67%
C:
1.67%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-12.87%
|
O:
-0.21%
H:
0.0%
C:
0.0%
report
global
growth
market
Nanomedicine Market to be Worth $410.15 Billion by 2030: Grand View Research, Inc.
Published:
2023-05-25
(Crawled : 09:00)
- prnewswire.com
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
52.72%
|
O:
-7.41%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
15.87%
|
O:
-0.49%
H:
0.0%
C:
0.0%
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-32.02%
|
O:
-0.31%
H:
0.0%
C:
-1.77%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-5.26%
|
O:
-1.37%
H:
0.0%
C:
-0.89%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-4.81%
|
O:
-0.39%
H:
0.15%
C:
-1.05%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
2.91%
|
O:
-0.74%
H:
0.25%
C:
-1.09%
ARWR
|
$23.775
-0.61%
-0.61%
830K
|
Health Technology
|
-32.75%
|
O:
-0.17%
H:
0.28%
C:
-5.46%
market
Alvotech and Advanz Pharma extend strategic partnership to commercialize five proposed biosimilars in Europe
Published:
2023-05-24
(Crawled : 09:00)
- globenewswire.com
ALVO
|
$13.39
0.45%
0.45%
200K
|
n/a
|
63.56%
|
O:
-4.91%
H:
3.35%
C:
0.26%
KMDA
|
$5.1
-0.99%
5.3K
|
Health Technology
|
10.9%
|
O:
15.6%
H:
5.73%
C:
-0.18%
partnership
europe
pharma
Global Protein Therapeutics Market Report 2023: Development of Plasma Derived Therapies Drives Growth
Published:
2023-05-23
(Crawled : 02:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
-6.2%
|
O:
0.7%
H:
1.22%
C:
-0.67%
NVO
|
News
|
$128.64
2.7%
-0.07%
3.7M
|
Health Technology
|
-26.54%
|
O:
-1.39%
H:
0.06%
C:
-2.77%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-4.94%
|
O:
0.15%
H:
0.74%
C:
-0.18%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
68.51%
|
O:
-0.25%
H:
0.69%
C:
-2.24%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-1.09%
|
O:
-0.88%
H:
0.17%
C:
-1.45%
ORMP
A
|
$2.39
2.58%
2.51%
31K
|
Health Technology
|
-47.4%
|
O:
0.9%
H:
10.29%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
-5.8%
|
O:
0.97%
H:
0.0%
C:
-1.46%
report
global
protein
therapeutics
growth
market
Autoimmune Drugs Market size to grow by USD 29,314.5 million between 2022 and 2027; AbbVie Inc., and AdvaCare Pharma among others, identified as key vendors - Technavio
Published:
2023-05-19
(Crawled : 00:20)
- prnewswire.com
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
pharma
abbvie
market
← Previous
1
2
…
5
6
7
8
9
10
11
12
13
…
31
32
Next →
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.